GAEU Consulting secures the prestigious EIC Accelerator funding for Lindhe Xtend

GAEU Consulting secures the prestigious EIC Accelerator funding for Lindhe Xtend. Our client receives 3.6 MEUR from EIC Accelerator blended funding scheme.

Lindhe Xtend, the Swedish company at the forefront of innovation in the field of prosthetics, will receive the prestigious EIC Accelerator grant and equity investment to finalise the development and commercialise its latest medical device. This market disruptive innovation is set to drastically increase the quality of life of millions of amputees across the world.

Jessika Broström, CEO Lindhe Xtend AB comments: “Working with GAEU was a true pleasure. Their thought-through and proven methodology of guiding you through the application process, step-by-step, was excellent. (...)” Check full references here: https://gaeu.com/client-references/lindhe-xtend

Tomasz Wąsik, CEO GAEU comments: “We are extremely happy to be given trust to support a project with that strong societal impact. This project will give amputees the ability to live a free and active life with high quality of life. We are honoured to be a part of this development. We wish Lindhe Xtend best of luck during project execution phase.”

About Lindhe Xtend AB:
Christoffer Lindhe, who experiences first-hand the daily problems of amputees, is the founder and principal owner of Lindhe Xtend AB. He founded the company as a young engineer eager to solve a simple problem: walking on uneven ground with prosthetics. This resulted in the company’s first product, the Xtend foot, and has led him to receive many awards and honours for his inventiveness, his company and his leadership. Today, Lindhe Xtend is a recognized innovator in the field of prosthetics that is expanding its commercial operations into more countries. The company mission is to increase the quality of life of amputees by developing products from the user’s point of view, with a very high focus on user-innovation.

Previous
Previous

SeaTwirl receives 5 MEUR from the Swedish Energy Agency

Next
Next

Genagon Therapeutics and Mosaique Diagnostics receive Eurostars funding